The abstract is read at the publisher; the summary is JClub's.
Peritumoral delivery of KCNA3 mRNA lipid nanoparticles in a humanized head and neck squamous cell carcinoma model significantly reduced tumor burden and increased CD8 Granzyme B T-cell infiltration.
- Why it matters: Immunotherapy often fails in HNSCC because tumor-infiltrating T cells cannot sustain calcium-dependent cytotoxic effector functions, linked to suppressed Kv1.3 activity in the tumor microenvironment.
- What they did: The study engineered anti-CD5 antibody–functionalized lipid nanoparticles to deliver mRNA encoding Kv1.3 (KCNA3) to T cells, then measured Kv1.3 protein/activity, Ca2+ influx, and effector cytokine and cytotoxic molecule secretion.
- The result: KCNA3-LNP treatment increased Kv1.3 channel expression and activity, boosted Ca2+ influx, elevated IL-2, IL-17, TNF-, and IFN-{gamma} plus Granzyme A, Perforin, Granulysin, and Fas ligand, and improved antitumor immunity in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.